Publications by authors named "A Gawron"

Background: Colorectal cancer (CRC) prevention is a Veterans Affairs (VA) priority. Colonoscopy quality, especially adenoma detection rate (ADR), is critical for effective screening. Our research indicates considerable variation in ADR among VA providers.

View Article and Find Full Text PDF

Background: Having a sufficient number of gastroenterologists is important for protecting the digestive health of veterans. However, gastroenterology is among the most difficult medical specialties for recruitment at the US Department of Veterans Affairs (VA).

Methods: We surveyed VA gastroenterology section chiefs to learn about current barriers to recruitment and retention and to identify opportunities for improvement.

View Article and Find Full Text PDF

This work describes a novel method for converting bismuth triiodide (BiI) microplates into bismuth oxyiodide (BiOI) nanoflakes under ultrasonic irradiation. To produce BiOI nanoflakes with a high yield and high purity, the conversion process was carefully adjusted. Rapid reaction kinetics and increased mass transfer are benefits of the ultrasonic-assisted approach that result in well-defined converted BiOI nanostructures with superior characteristics.

View Article and Find Full Text PDF

The aim of this study was to verify whether the level of mental resilience would differentiate reading comprehension performance when using different information carriers. More than 150 people filled out a test regarding the level of resilience. They then participated in a survey using fNIRS.

View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed the use of infliximab (IFX) and its biosimilars (IFX-dyyb and IFX-abda) among Veterans with Inflammatory Bowel Disease (IBD), focusing on a group of 1763 IFX-naïve patients over a 365-day period after starting treatment.
  • - Patients were monitored for IFX utilization patterns, dosing, adherence, and persistence, with results indicating differences in these measures across the three treatment groups.
  • - Key findings showed variation in the proportion of days covered and persistence rates, with IFX-RP, IFX-dyyb, and IFX-abda having coverage rates of 66%, 60%, and 69%
View Article and Find Full Text PDF